Humasis participates Dubai MEDLAB Middle East 2023

South Korean medical devices maker, Humasis Co., is participating in the MEDLAB Middle East 2023 event taking place at the Dubai World Trade Center from Feb. 6 to 9, the company said on Tuesday. 

The event, considered the world's largest diagnostic and medical device fair, will bring together researchers, distributors, and manufacturers to network and showcase innovative technologies.

At the event, Humasis is showcasing a range of products focused on the chronic disease market in the Middle East and Africa, including specialized equipment for diabetes clinics (HUBIDIA), a high-sensitivity malaria antigen test kit, a point-of-care testing (POCT) analyzer (HUBITAS), and a diagnostic kit for myocardial infarction.

"In the Middle East and Africa, the number of diabetic and obese patients is increasing significantly due to relatively unhealthy lifestyles and eating habits. We aim to promote our products to establish a strong presence in the chronic disease market," said a Humasis official.

The official also noted the high mortality rate from malaria in Africa and the difficulties in blocking its spread due to mutated strains. The company believes its products, capable of diagnosing mutant malaria, have high market potential in the region.

Write to Jae-Young Han at jyhan@hankyung.com